IRWD Chart
- 52-Week Range: $10.61 - $13.95
- Market Capitalization: $1.75B
- Short Percentage: 0%
- Target Price: $13.00
- Shares Outstanding: 153.84M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
IRWD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Ironwood Pharmaceuticals, Inc. (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 17th
- Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Investor Update CallBusiness Wire | February 3rd
- Ironwood Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare ConferenceBusiness Wire | January 5th
- Ironwood Pharmaceuticals Appoints Sravan K. Emany as Chief Financial OfficerBusiness Wire | December 1st
- Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 6th
- Ironwood Pharmaceuticals to Host Third Quarter 2021 Investor Update CallBusiness Wire | October 21st
Company Info
Website: https://www.ironwoodpharma.com
Address: 100 Summer Street, Boston, MA, United States, 02110
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 219
Address: 100 Summer Street, Boston, MA, United States, 02110
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 219
$IRWD lets see if it can hold the line
$IRWD Now I'm worried....
$IRWD let’s go baby!
$IRWD we back
$IRWD time will come
$IRWD today feels different to the moon
$IRWD Hedgies
we aren't going anywhere!
$IRWD Slapping that ask today
$IRWD GET IN mofos!!!
$IRWD when this finally break out we could see huge upside